100+ Free Fachapotheker/in FPH Offizin Practice Questions

Prepare for the Fachapotheker/in FPH in Offizinpharmazie / Pharmacien/ne spécialiste FPH en pharmacie d'officine exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Swiss FPH Pharmacy Specialist Examinations (Fachapotheker FPH)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Fachapotheker/in FPH Spital (Switzerland)

Practice Questions100 questions

2026 Statistics

Key Facts: Fachapotheker/in FPH Offizin Exam

100 MCQs

Exam Format

FPH Offizin Examination Regulations

210 min

Exam Duration (09:00–12:30)

FPH Examination Standard

CHF 416.20

Member Fee (incl. VAT)

pharmaSuisse / FPH Fee Schedule

584 Days

Min. Practical Training

FPH Weiterbildungsprogramm

Lifetime

Federal Title Validity

MedBG / BAG

100

Practice Questions

OpenExamPrep

The Fachapotheker/in FPH in Offizinpharmazie title certifies specialist community pharmacists in Switzerland through Institut FPH and pharmaSuisse. The final board examination consists of 100 MCQs in 210 minutes (09:00–12:30), testing clinical triage (NetCare, vaccination), chronic disease pharmacotherapy, drug interactions, Swiss pharmaceutical law (HMG, BetmG), and magistral compounding.

Sample Fachapotheker/in FPH Offizin Practice Questions

Try these sample questions to test your Fachapotheker/in FPH Offizin exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 24-year-old non-pregnant woman presents to the community pharmacy complaining of acute dysuria, increased urinary urgency, and pollakiuria for 24 hours. She has no fever, no flank or back pain, no vaginal discharge, and no history of recurrent urinary tract infections. Under the Swiss NetCare consultation protocol and infectious disease guidelines (SSI), what is the most appropriate first-line pharmaceutical management?

A.Dispense a single oral dose of Fosfomycin trometamol (3 g) after protocolized consultation and urine test strip assessment, with advice on hydration and alarm symptoms

B.Dispense oral Ciprofloxacin (500 mg twice daily for 5 days) as empirical first-line bactericidal therapy

C.Refuse pharmacy dispensing and refer the patient immediately to an emergency department for systemic intravenous antibiotic administration

D.Recommend Cranberry extract capsules and D-mannose as exclusive curative therapy without offering an evidence-based antibiotic

Explanation: Under the Swiss NetCare algorithm for uncomplicated cystitis in women aged 18–65 without red flags (fever >38°C, flank pain/CVA tenderness, pregnancy, diabetes, or immunosuppression), the pharmacist is authorized to triage and dispense first-line antibiotics such as Fosfomycin trometamol (3 g single dose) or Nitrofurantoin (100 mg twice daily for 5 days).

2A 32-year-old man visits the pharmacy complaining of a severe sore throat and pain when swallowing for 2 days. Examination reveals a body temperature of 38.8°C, swollen anterior cervical lymph nodes, tonsillar exudate, and no cough (Centor/McIsaac score 4). According to the Swiss NetCare pharyngitis protocol, what is the mandatory next step before considering antibiotic dispensing?

A.Immediately dispense oral Amoxicillin/Clavulanic acid based solely on the high clinical Centor score

B.Perform a Strep A rapid antigen detection test (RADT); dispense Amoxicillin (or Penicillin V) only if the test is positive

C.Dispense a topical steroid throat spray and advise immediate gargling with chlorhexidine solution as definitive treatment

D.Refer the patient for urgent tonsillectomy at a cantonal hospital

Explanation: Even with a high Centor/McIsaac score (≥3–4), clinical criteria alone cannot distinguish viral from Group A Streptococcal (GAS) pharyngitis with certainty. The NetCare protocol mandates performing a validated Strep A rapid antigen test in the consultation room; narrow-spectrum antibiotics (Amoxicillin 50 mg/kg/day or Penicillin V) are dispensed only if the test is positive.

3A 21-year-old woman requests emergency contraception at the pharmacy 96 hours (4 days) after an episode of unprotected intercourse. She has no chronic medical conditions and takes no regular medications. Which emergency contraceptive option is recommended by Swiss guidelines, and what key counseling point regarding hormonal contraception is essential?

A.Levonorgestrel (1.5 mg) is indicated up to 120 hours, and regular combined oral contraceptives can be restarted immediately without backup protection

B.Levonorgestrel (3.0 mg) is the only approved option beyond 72 hours, but causes irreversible endometrial thinning

C.Ulipristal acetate (30 mg) is indicated up to 120 hours; after ingestion, hormonal contraceptives should NOT be restarted for 5 days, and barrier contraception is required until the next menses

D.Emergency contraception cannot be used after 72 hours, and the patient must be referred for elective surgical termination

Explanation: Ulipristal acetate (EllaOne 30 mg) is a selective progesterone receptor modulator licensed for emergency contraception up to 120 hours (5 days) post-coitus and is superior to levonorgestrel after 72 hours. Because ulipristal binds progesterone receptors, starting or resuming progestin-containing hormonal contraceptives immediately reduces ulipristal's efficacy; patients must wait 5 days before resuming hormonal contraceptives and use barrier methods for 7–14 days thereafter.

4Under the Swiss FPH Certificate of Competence in Vaccination and Blood Sampling (Fähigkeitsausweis FPH Impfen und Blutentnahme) and cantonal public health legislation, which vaccine can an accredited community pharmacist independently administer without a medical prescription to an eligible, healthy adult aged 18 or older?

A.Intravenous immunoglobulin infusion for autoimmune polyneuropathy

B.Yellow fever live attenuated vaccine for tropical travel without specialized yellow fever center accreditation

C.Live oral typhoid vaccine capsules to pregnant women in their first trimester

D.Tick-borne encephalitis (FSME / TBE) vaccine as primary immunization or booster

Explanation: Accredited Swiss community pharmacists holding the FPH Certificate of Competence in Vaccination and valid BLS-AED certification are authorized under cantonal regulations to independently assess, triage, and administer routine vaccinations—including FSME (tick-borne encephalitis), seasonal influenza, hepatitis A/B, COVID-19, and Shingrix—to healthy adults.

5Ten minutes after receiving an intramuscular seasonal influenza vaccine in the pharmacy consultation room, a 48-year-old woman develops generalized urticaria, facial angioedema, inspiratory stridor, severe wheezing, and lightheadedness (blood pressure 80/50 mmHg). What is the immediate first-line pharmaceutical intervention and protocol according to Swiss FPH and Resuscitation Council standards?

A.Administer Adrenaline (Epinephrine) 0.3 mg intramuscularly into the anterolateral mid-thigh, place the patient supine with legs elevated, and immediately call emergency services (144)

B.Administer oral Cetirizine 10 mg with a glass of water and wait 30 minutes to evaluate symptom progression

C.Inject Intravenous Hydrocortisone 500 mg slowly over 20 minutes as the primary life-saving drug

D.Place the patient in an upright seated position, provide an oral warm glucose drink, and arrange a routine primary care visit

Explanation: Intramuscular Adrenaline (Epinephrine) 0.3 mg (1:1000, 1 mg/mL) injected into the anterolateral mid-thigh is the immediate, life-saving first-line treatment for anaphylaxis. Positioning the patient supine with elevated legs prevents empty ventricle syndrome and circulatory collapse. Emergency services (144) must be called immediately, and adrenaline can be repeated every 5–10 minutes if no improvement occurs.

6A 40-year-old hiker presents to the pharmacy with an expanding, painless, erythematous circular skin lesion (9 cm in diameter with slight central clearing) on his left thigh, which appeared 12 days after removing a tick. He has mild malaise but no joint swelling or neurological deficits. What is the clinical diagnosis and guideline-recommended management under Swiss primary care standards?

A.Early localized Lyme Borreliosis (Erythema migrans); initiate oral Doxycycline 100 mg twice daily for 10–14 days (or refer via NetCare) without waiting for serological antibody testing

B.Immediate tick bite hypersensitivity; apply topical hydrocortisone 1% cream for 3 days and avoid oral antibiotics

C.Late stage neuroborreliosis; arrange immediate hospital admission for 4 weeks of continuous intravenous Ceftriaxone

D.Secondary cutaneous candidiasis; dispense topical Clotrimazole 1% cream for 4 weeks

Explanation: Erythema migrans is the pathognomonic clinical manifestation of early Lyme borreliosis (Borrelia burgdorferi sensu lato). In Switzerland, serological antibody testing is NOT recommended at this stage because antibodies (IgM/IgG) are frequently negative in the first 2–4 weeks; prompt oral Doxycycline (100 mg bid for 10–14 days) or Amoxicillin (500 mg tid for 14 days in pregnancy/children) prevents dissemination.

7A 28-year-old woman taking Carbamazepine (400 mg twice daily) for focal epilepsy requests emergency contraception at the pharmacy 36 hours after condom failure. Based on Swiss and European clinical pharmacotherapy guidelines, what is the most appropriate recommendation?

A.Dispense standard single-dose Levonorgestrel (1.5 mg) because antiepileptic drugs do not alter progestin pharmacokinetics

B.Dispense Ulipristal acetate (30 mg), as its efficacy is unaffected by hepatic enzyme-inducing medications

C.Double the dose of Levonorgestrel to 3.0 mg (two 1.5 mg tablets taken simultaneously), or recommend urgent insertion of a copper intrauterine device (Cu-IUD) within 5 days

D.Withhold emergency contraception entirely because all hormonal methods are strictly contraindicated in patients with epilepsy

Explanation: Carbamazepine is a potent inducer of hepatic CYP3A4 enzymes, accelerating the metabolism of emergency contraceptives. For women taking liver enzyme-inducing drugs within the past 4 weeks, guidelines recommend doubling the levonorgestrel dose to 3.0 mg (two 1.5 mg tablets) or placing a copper IUD (the most effective method). Ulipristal acetate is not recommended because enzyme induction drastically reduces its efficacy, and doubling ulipristal's dose has not been clinically validated.

8A 29-year-old soft contact lens wearer presents to the community pharmacy with a painful, unilateral red right eye, photophobia, reduced visual acuity, and a sensation of a foreign body that began yesterday. What is the mandatory triage action by the pharmacist?

A.Dispense OTC vasoconstrictor eye drops (e.g. tetryzoline) and artificial tears for 5 days

B.Dispense OTC topical chloramphenicol eye drops and advise continued contact lens wear

C.Recommend cold compresses and an oral antihistamine for presumed contact lens-associated allergy

D.Immediately refer the patient to an ophthalmologist or eye emergency clinic on the same day to rule out infectious keratitis (e.g. Pseudomonas or Acanthamoeba)

Explanation: In contact lens wearers, a painful red eye accompanied by reduced visual acuity, photophobia, and foreign body sensation is an ophthalmic emergency. It strongly raises suspicion of infectious microbial (often Pseudomonas aeruginosa) or Acanthamoeba keratitis, which can lead to corneal ulceration, perforation, and permanent blindness within 24–48 hours if untreated.

9A 58-year-old man visits the pharmacy requesting an OTC proton pump inhibitor (e.g. Pantoprazole 20 mg). During the consultation, he mentions that he has had new-onset daily epigastric burning for 4 weeks, has lost 4 kg unintentionally, and occasionally feels food 'sticking' behind his sternum when swallowing. What is the appropriate triage decision?

A.Withhold OTC self-medication and refer the patient promptly to a physician for diagnostic upper gastrointestinal endoscopy

B.Dispense Pantoprazole 20 mg daily for 14 days and instruct the patient to return only if symptoms worsen after 1 month

C.Recommend switching to high-dose calcium/magnesium antacid chewable tablets 1 hour after meals

D.Reassure the patient that new-onset dysphagia and weight loss are normal physiologic signs of gastric aging

Explanation: Alarm symptoms (Red Flags) in dyspepsia/reflux include new onset of symptoms in individuals >50 years, unintentional weight loss, progressive dysphagia (difficulty swallowing), odynophagia, persistent vomiting, or signs of GI bleeding/anemia. Dispensing a PPI in this scenario risks masking the symptoms of upper gastrointestinal malignancy (esophageal or gastric adenocarcinoma) and delaying life-saving endoscopy.

10A 64-year-old woman presents to the pharmacy with a 36-hour history of a painful, burning vesicular skin rash strictly localized in a band-like unilateral distribution across her left ribcage (T5 dermatome). What is the optimal therapeutic window and first-line treatment for this condition in Swiss community pharmacy practice?

A.Initiate oral antiviral therapy (e.g. Valacyclovir 1000 mg 3 times daily for 7 days) within 72 hours of rash onset to accelerate healing and reduce the risk of postherpetic neuralgia

B.Apply topical Acyclovir cream 5 times daily as definitive monotherapy, as oral antivirals are contraindicated in dermatomal zoster

C.Withhold all medications until all vesicles have crusted over, then initiate topical capsaicin cream

D.Dispense oral Doxycycline 100 mg daily for 21 days to treat secondary bacterial colonization

Explanation: For Herpes Zoster (shingles), initiating systemic oral antiviral therapy (Valacyclovir 1000 mg tid, Famciclovir 500 mg tid, or Brivudine 125 mg once daily [in non-immunocompromised patients without 5-FU co-medication]) within 72 hours of cutaneous lesion onset significantly shortens acute viral shedding, speeds cutaneous healing, and reduces the severity and duration of postherpetic neuralgia (PHN), particularly in patients ≥50 years.

About the Fachapotheker/in FPH Offizin Exam

The Fachapotheker/in FPH in Offizinpharmazie (Specialist in Community Pharmacy FPH) is the federally recognized postgraduate title governed by the Federal Act on Medical Professions (MedBG) and regulated by the Institut FPH and pharmaSuisse. It is the mandatory qualification for independent community pharmacy practice and pharmacy directorship (fachliche Leitung) across Switzerland. The postgraduate curriculum encompasses seven professional roles, with Role 1 ('Pharmaceutical Expert' / 'Pharmazeutischer Experte') forming the foundation of the final board examination. The examination tests evidence-based self-medication triage, NetCare consultation protocols, pharmacy vaccination services, complex pharmacotherapy management in chronic diseases, drug-drug and drug-disease interactions, Swiss pharmaceutical legislation (Heilmittelgesetz HMG, Betäubungsmittelgesetz BetmG, Swissmedic categories A, B, D), LOA health insurance tariff structures, magistral compounding according to Pharmacopoea Helvetica, quality assurance, and pharmacovigilance. Note on examination format and language: The official FPH board examination is administered in Switzerland's national languages (German, French, or Italian) as a 100-MCQ 210-minute paper. This question bank is an English-language multiple-choice study adaptation developed by OpenExamPrep—not an official FPH release—specifically created to train candidates, foreign pharmacists seeking federal title recognition, and postgraduate trainees in high-yield clinical decision-making, regulatory frameworks, and Swiss pharmacy standards.

Assessment

Single comprehensive 210-minute written examination comprising 100 multiple-choice questions (single-best answer / Type A format). The examination is conducted centrally twice per year (spring and autumn) under the auspices of the FPH Offizin Examination Committee and covers clinical triage, pharmacotherapy, drug safety, Swiss pharmaceutical law, LOA tariffs, and magistral compounding.

Time Limit

210 minutes (3 hours 30 minutes, 09:00–12:30)

Passing Score

Criterion-referenced passing standard set by the FPH Examination Committee (typically ≥60% correct responses)

Exam Fee

CHF 416.20 for pharmaSuisse members / CHF 502.70 for non-members (inclusive of 8.1% VAT) (Institut FPH / Fachgesellschaft FPH Offizin (pharmaSuisse))

Fachapotheker/in FPH Offizin Exam Content Outline

25%

Clinical Services, Triage & Primary Care Protocols (NetCare, Vaccination, Self-Medication)

Standardized NetCare decision algorithms (uncomplicated cystitis, acute pharyngitis/Strep A test, acute rhinosinusitis, tick bites/erythema migrans, shingles, eye/ear triage), emergency contraception protocols (ulipristal vs levonorgestrel, BMI impact, enzyme inducers), pharmacy vaccination services under FPH certification (influenza, FSME/TBE, Shingrix, COVID-19, emergency anaphylaxis management with IM adrenaline), and evidence-based self-medication triage for gastrointestinal, dermatological, respiratory, and musculoskeletal conditions.

30%

Chronic Disease Management & Clinical Pharmacotherapy

Comprehensive pharmacotherapeutic management of chronic conditions according to current clinical guidelines (ESC/ESH, GINA, GOLD, SGED, ADA): cardiovascular diseases (hypertension triple therapy, HFrEF four pillars, dyslipidemia statin/ezetimibe/PCSK9 hierarchy, DOAC and VKA anticoagulation), metabolic disorders (type 2 diabetes SGLT2i/GLP-1 RA/metformin safety), respiratory conditions (GINA MART strategy, GOLD LABA/LAMA/ICS criteria), psychiatry (SSRIs/SNRIs, benzodiazepines), and neurology (antiepileptic titration, Parkinson disease).

20%

Drug Interactions, Contraindications & Patient Safety

Pharmacokinetic and pharmacodynamic drug-drug interactions (CYP3A4/CYP2D6/CYP2C9 inducers and inhibitors, P-glycoprotein modulators, 'triple whammy' nephrotoxicity, serotonin syndrome, QT prolongation risks, hyperkalemia synergy), pharmacogenomic considerations (DPYD, HLA-B*5801), and medication safety in special populations (pregnancy and lactation teratogenicity, pediatric contraindications, and geriatric prescribing via PRISCUS/Beers criteria and anticholinergic burden).

15%

Swiss Pharmaceutical Law, Narcotics & Healthcare Tariffs

Swiss therapeutic products legislation (Heilmittelgesetz HMG, Swissmedic dispensing categories A, B, D, E, pharmacist independent dispensing under Art. 24 HMG), narcotics regulation (Betäubungsmittelgesetz BetmG, BetmKV, official 3-part narcotic prescription forms, 1-month/3-month supply limits, safe storage, and mandatory register), cantonal healthcare legislation (supervision by Kantonsapotheker, pharmacy operating license, responsible pharmacist requirements under MedBG), and LOA health insurance tariff structures (Medikamenten-Check, Bezugs-Check, emergency out-of-hours fees, and generic/biosimilar substitution rules).

10%

Magistral Compounding, Quality Assurance & Pharmacovigilance

Good compounding practice for small-scale manufacturing in accordance with Pharmacopoea Helvetica (Ph. Helv.) and European Pharmacopoeia (Ph. Eur.), Formula Magistralis and Formula Officinalis preparation, beyond-use dating (BUD) for aqueous/non-aqueous formulations, cold chain management (2–8°C) and temperature deviation protocols, pharmacy quality management systems (QMS pharmaSuisse), Critical Incident Reporting System (CIRS), and Swissmedic pharmacovigilance mandatory reporting deadlines (15 days for serious, 60 days for non-serious ADRs).

How to Pass the Fachapotheker/in FPH Offizin Exam

What You Need to Know

Passing score: Criterion-referenced passing standard set by the FPH Examination Committee (typically ≥60% correct responses)
Assessment: Single comprehensive 210-minute written examination comprising 100 multiple-choice questions (single-best answer / Type A format). The examination is conducted centrally twice per year (spring and autumn) under the auspices of the FPH Offizin Examination Committee and covers clinical triage, pharmacotherapy, drug safety, Swiss pharmaceutical law, LOA tariffs, and magistral compounding.
Time limit: 210 minutes (3 hours 30 minutes, 09:00–12:30)
Exam fee: CHF 416.20 for pharmaSuisse members / CHF 502.70 for non-members (inclusive of 8.1% VAT)

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Fachapotheker/in FPH Offizin Study Tips from Top Performers

1Master NetCare Decision Trees & Triage Algorithms: Be completely fluent in protocolized triage for uncomplicated cystitis (fosfomycin/nitrofurantoin), acute pharyngitis (McIsaac score and Strep A testing), tick bites (erythema migrans management), and red flags requiring immediate medical referral.

2Know Swissmedic Dispensing Categories & Art. 24 HMG Rules: Understand the boundaries of Category A (single medical prescription), Category B (prescription or pharmacist dispensing under Art. 24 for defined self-treatable indications or continuing therapy), and Category D (expert advice in pharmacies/drugstores).

3Memorize Swiss Narcotics (BetmG) Regulations: Remember the 1-month prescription validity period, maximum 1-month supply (extendable to 3 months with physician justification), mandatory locked safe storage, and continuous balance logging in the Betäubungsmittelkontrolle.

4Review Guideline-Directed Chronic Pharmacotherapy: Master the 4 pillars of HFrEF (ARNI, beta-blocker, MRA, SGLT2i), GINA MART strategy for asthma (ICS-formoterol as reliever and controller), GOLD COPD criteria (blood eosinophils ≥300 for ICS addition), and DOAC renal dosing rules.

5Understand Ph. Helv. Compounding & Quality Safety: Learn beyond-use dates (BUD) for unpreserved aqueous formulations (14 days refrigerated), cold chain excursion management (quarantine at 2–8°C), and Swissmedic pharmacovigilance reporting timeframes (15 days for serious ADRs).

Frequently Asked Questions

What is the Fachapotheker/in FPH in Offizinpharmazie title?

The Fachapotheker/in FPH in Offizinpharmazie is the federally recognized postgraduate specialist title for community pharmacists in Switzerland. Conferred by the Institut FPH and pharmaSuisse under the Federal Act on Medical Professions (MedBG), it is required for independent pharmacy practice and serving as a managing responsible pharmacist (fachliche Leitung) across all Swiss cantons.

How is the FPH Offizin final examination structured?

The examination is a written assessment consisting of 100 multiple-choice questions (MCQs) administered over 210 minutes (3.5 hours, 09:00–12:30). It is held twice annually in spring and autumn in Switzerland's national languages (German, French, Italian) and primarily evaluates competency in Role 1 (Pharmaceutical Expert).

When can postgraduate trainees register for the examination?

Under the revised FPH regulations (effective 2026), trainees can register for the examination once they have achieved the required 1,500 FPH points and competency assessments for Role 1, even before completing all practical training days and remaining role requirements.

What are the practical training requirements for the FPH specialist title?

Candidates must complete at least 584 full-time days of supervised practical training (minimum 2 years at 80–100% employment or up to 5 years part-time) in an accredited Swiss training pharmacy, alongside acquiring 5,000 total FPH points across all 7 professional roles.

What key Swiss legal frameworks are tested on the examination?

The examination tests the Federal Act on Medicinal Products and Medical Devices (Heilmittelgesetz HMG), Swissmedic dispensing categories (A, B, D, E), pharmacist dispensing rights under Art. 24 HMG, the Narcotics Act (Betäubungsmittelgesetz BetmG and BetmKV), LOA health insurance tariffs (KVG/LAMal), and Pharmacopoea Helvetica compounding rules.

Why is this practice bank provided in English?

While the official Swiss FPH examination is conducted in German, French, or Italian, this English-language MCQ bank is an educational study adaptation created by OpenExamPrep. It allows candidates and international pharmacists seeking MEBEKO title recognition to practice high-yield clinical decision-making, pharmacotherapeutic guidelines, and Swiss regulatory concepts in a standardized format.